Skip to main content
. 2024 Apr 23;134(11):e176466. doi: 10.1172/JCI176466

Table 3. Regression analysis of anti–PF4/P IgG with clinical outcomes/complications in Ret+ CM.

graphic file with name jci-134-176466-g220.jpg